Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Dermatitis. 2014 Mar-Apr;25(2):56–59. doi: 10.1097/DER.0000000000000019

Table 4.

Previous Therapies

Use of TCS 61 (81%)
  Low potency 25 (33%)
  Mid potency 27 (36%)
  High potency 9 (12%)
Calcineurin inhibitors 15 (20%)
Systemic steroids 15 (20%)
Antihistamines 26 (35%)
Antibiotics 26 (35%)
UV therapy 2 (3%)